7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies
August 04, 2020 05:00 ET
|
7 Hills Pharma
HOUSTON, Aug. 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
7 Hills Pharma Announces Positive Data With Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines
July 07, 2020 05:00 ET
|
7 Hills Pharma
Studies show the small molecule adjuvant significantly increases IgG binding antibody responses Company establishes scalable manufacturing supply chain to meet pandemic demands HOUSTON, July 07,...
7 Hills Pharma Highlights Cell Adhesion as Key to Improving Effectiveness of Covid-19 Vaccines and Immuno-Oncology Drugs At BIO Digital 2020 Online Conference
June 15, 2020 10:39 ET
|
7 Hills Pharma
HOUSTON, June 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
7 Hills Pharma to Deliver Video Presentation At BIO Digital 2020 June 8 – 12
June 04, 2020 12:58 ET
|
7 Hills Pharma
Company is leveraging its integrin platform technology to improve effectiveness of immunotherapies, including Covid-19 vaccines HOUSTON, June 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a...
7 Hills Pharma Announces Coronavirus Vaccine Program Targeting At-Risk Elderly
April 15, 2020 08:00 ET
|
7 Hills Pharma
HOUSTON, April 15, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases,...
7 Hills Pharma Announces FDA Clearance of Investigational New Drug Application for 7HP349, a First-in-Class Immune Stimulant
April 14, 2020 08:00 ET
|
7 Hills Pharma
HOUSTON, April 14, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
7 Hills Pharma Appoints Lionel D. Lewis as Chief Medical Officer
July 24, 2018 08:00 ET
|
7 Hills Pharma
HOUSTON, July 24, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, today announced the...
7 Hills Pharma Announces Scientific Advisory Board Formed With Prominent Immuno-Oncology Experts to Help Advance Novel Integrin Activator Program
June 26, 2018 08:00 ET
|
7 Hills Pharma
HOUSTON, June 26, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, announced today the formation...
7 Hills Pharma Launches With $2 Million SBIR Grant in Addition to $4 Million in Seed Capital to Pursue Novel Cancer Therapeutics to Promote a Productive Immune Response and Overcome Drug Resistance
June 19, 2018 08:00 ET
|
7 Hills Pharma
HOUSTON, June 19, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, announced today that it has...